Author:
Choera Tsokyi,Jung-Hynes Brittney,Chen Derrick J.
Abstract
Abstract
Background
Group B Streptococcal (GBS) infections in the United States are a leading cause of meningitis and sepsis in newborns. The CDC therefore recommends GBS screening for all pregnant women at 35–37 weeks of gestation and administration of intrapartum prophylaxis (in those that tested positive) as an effective means of controlling disease transmission. Several FDA approved molecular diagnostic tests are available for rapid and accurate detection of GBS in antepartum women.
Method
In this study, we report a clinical comparison of the Xpert GBS LB assay and a novel FDA-cleared test, Revogene GBS LB assay. A total of 250 vaginal-rectal swabs from women undergoing prenatal screening were submitted to the University of Wisconsin’s clinical microbiology laboratory for GBS testing.
Results
We found 96.8% of samples were concordant between the two tests, while 3.2% were discordant with a positive percent agreement of 98.0% and a negative percent agreement of 96.5% between the Revogene GBS LB assay and the GeneXpert GBS LB assay.
Conclusion
Overall, we report that both assays perform well for the detection of GBS colonization in pregnant women.
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases NCfI, Respiratory Diseases CfDC, Prevention. 2010. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59:1–36. https://www.ncbi.nlm.nih.gov/pubmed/21088663.
2. Haleis A, Alfa M, Gottschalk M, Bernard K, Ronald A, Manickam K. Meningitis caused by Streptococcus suis serotype 14, North America. Emerg Infect Dis. 2009;15:350–2.
3. Ke D, Menard C, Picard FJ, Boissinot M, Ouellette M, Roy PH, Bergeron MG. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin Chem. 2000;46:324–31.
4. Ke D, Bergeron MG. Molecular methods for rapid detection of group B streptococci. Expert Rev Mol Diagn. 2001;1:175–81.
5. Jakobi P, Goldstick O, Sujov P, Itskovitz-Eldor J. New CDC guidelines for prevention of perinatal group B streptococcal disease. Lancet. 1996;348:969.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献